- Ticker
- AKYA
- Price
- 4.30
- Stock movement down
- -0.29 (-6.32%)
- Company name
- Akoya Biosciences Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Medical Instruments & Supplies
- Markedsverdi
- 164.87M
- Ent verdi
- 208.09M
- Pris/omsetning
- 2.20
- Pris/bok
- 2.81
- Utbytte avkastning
- -
- Utbytte vekst
- -
- Vekst år
- -
- FCF-utbetaling
- -
- Etterfølgende P/E
- -
- Fremtidig P/E
- -
- PEG
- -
- EPS-vekst
- -
- 1 års avkastning
- -65.74%
- 3 års avkastning
- -
- 5 års avkastning
- -
- 10 års avkastning
- -
Sist oppdatert: 2023-12-06
Akoya Biosciences, Inc. (NASDAQ:NASDAQ:AKYA) Q3 2023 Earnings Conference Call November 8, 2023 5:00 PM ETCompany ParticipantsPriyam Shah - Head of Investor...
11. november 2023
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from Akoya Biosciences, Inc. (AKYA) stock at Seeking Alpha.
8. november 2023
iO Charts is a Seeking Alpha partner
UTBYTTE
AKYA betaler ikke utbytte
Akoya Biosciences' stock price has declined since joining Nasdaq in April 2021, with increasing operating losses and limited cash. Learn more on AKYA stock here.
8. august 2023
iO Charts is a Seeking Alpha partner
Akoya Biosciences, Inc. (NASDAQ:NASDAQ:AKYA) Q2 2023 Earnings Conference Call August 7, 2023 5:00 PM ETCompany ParticipantsPriyam Shah - Head of Investor...
8. august 2023
iO Charts is a Seeking Alpha partner
VERDSETTELSE
Verdsettelsesforhold
Loading...
Verdsettelsesforhold-data
| Etterfølgende P/E | - |
| Pris til OCF | - |
| Pris til FCF | - |
| Pris til EBITDA | - |
| EV i forhold til EBITDA | - |
Verdsettelse (Salg/Bokført verdi)
Loading...
Verdsettelse (Salg/Bokført verdi) data
| Pris til omsetning | 2.20 |
| Pris til bok | 2.81 |
| EV i forhold til salg | 2.78 |
Get the latest news and real-time alerts from Akoya Biosciences, Inc. (AKYA) stock at Seeking Alpha.
7. august 2023
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from Akoya Biosciences, Inc. (AKYA) stock at Seeking Alpha.
13. juni 2023
iO Charts is a Seeking Alpha partner
ØKONOMI
Per aksje
Loading...
Per aksje-data
| Gjeldende aksje antall | 38.34M |
| EPS (TTM) | -1.87 |
| FCF per aksje (TTM) | -1.61 |
Resultatregnskap
Loading...
Resultatregnskap-data
| Inntekter (TTM) | 74.86M |
| Bruttofortjeneste (TTM) | 43.39M |
| Driftsinntekter (TTM) | -66.11M |
| Netto inntekt (TTM) | -70.64M |
| EPS (TTM) | -1.87 |
| EPS (1 år fremover) | -1.60 |
Marginer
Loading...
Marginer-data
| Bruttomargin (TTM) | 57.96% |
| Driftsmargin (TTM) | -88.31% |
| Fortjenestemargin (TTM) | -94.37% |
Balanse
Loading...
Opprett en gratis konto eller logg inn for å få tilgang til dette diagrammet
Balanse-data
| Kontanter | 74.23M |
| Netto fordringer | 9.73M |
| Samlede omløpsmidler | 112.20M |
| Goodwill | 18.26M |
| Immaterielle eiendeler | 20.05M |
| Eiendom, anlegg og utstyr | 0.00 |
| Sum eiendeler | 176.03M |
| Leverandørgjeld | 10.63M |
| Kortsiktig/nåværende langsiktig gjeld | 75.78M |
| Sum kortsiktig gjeld | 37.05M |
| Sum gjeld | 117.45M |
| Aksjonærenes egenkapital | 58.58M |
| Netto varige driftsmidler | 20.27M |
Kontantstrøm
Loading...
Opprett en gratis konto eller logg inn for å få tilgang til dette diagrammet
Kontantstrøm-data
| Kontantstrøm fra drift (TTM) | -53.50M |
| Kapitalutgifter (TTM) | 7.36M |
| Fri kontantstrøm (TTM) | -60.86M |
| Utbetalt utbytte (TTM) | 0.00 |
Finansielle inntekter
Loading...
Opprett en gratis konto eller logg inn for å få tilgang til dette diagrammet
Finansielle inntekter-data
| Egenkapitalavkastning | -120.59% |
| Avkastning på eiendeler | -40.13% |
| Avkastning på investert kapital | -56.29% |
| Kontantavkastning på investert kapital | -48.50% |
Get the latest news and real-time alerts from Akoya Biosciences, Inc. (AKYA) stock at Seeking Alpha.
8. juni 2023
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from Akoya Biosciences, Inc. (AKYA) stock at Seeking Alpha.
7. juni 2023
iO Charts is a Seeking Alpha partner
AKSJEINFORMASJON
Aksjediagram
Loading...
Aksjekurs-data
| Åpning | 4.66 |
| Daglig høy | 4.70 |
| Daglig lav | 4.26 |
| Daglig volum | 187K |
| Tidenes høyeste | 26.05 |
| 1 år analytikerestimat | 18.00 |
| Beta | - |
| EPS (TTM) | -1.87 |
| Utbytte per aksje | - |
| Ex-div dato | - |
| Neste dato for resultatpresentasjon | 4 Mar 2024 |
Nedsidepotensial
Loading...
Nedsidepotensial-data
| AKYA | S&P500 | |
| Nåværende prisfall fra toppnotering | -83.49% | -4.80% |
| Høyeste prisfall | -87.98% | -56.47% |
| Dato for høyeste fall | 27 Oct 2023 | 9 Mar 2009 |
| Gj.snittlig fall fra topp | -56.24% | -11.47% |
| Gj.snittlig tid til ny topp | 667 days | 13 days |
| Maks tid til ny topp | 666 days | 1805 days |
Akoya Biosciences, Inc. (NASDAQ:NASDAQ:AKYA) Q1 2023 Earnings Conference Call May 8, 2023 5:00 PM ETCompany ParticipantsPriyam Shah - Investor...
9. mai 2023
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from Akoya Biosciences, Inc. (AKYA) stock at Seeking Alpha.
8. mai 2023
iO Charts is a Seeking Alpha partner
SELSKAPSOPPLYSNINGER
Markedsverdi
164.87M
Markedsverdi kategori
Small-cap
Beskrivelse
Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition; and PhenoImager platform that enables researchers to visualize, analyze, quantify, and phenotype cells in situ, in fresh frozen or FFPE tissue sections, and tissue microarrays utilizing an automated and high-throughput workflow. It also provides PhenoCycler and PhenoImager reagents; and biopharma services. In addition, the company offers analysis software partnerships ecosystem; inForm Tissue, an automated image analysis software package for accurately visualizing and quantifying biomarkers in tissue sections; Phenoptr, which provides functions that consolidate and analyze output tables created by inForm software; and phenoptrReports, a software that generates shareable reports and visualizations based on the phenoptr output in an intuitive front-end GUI. The company was incorporated in 2015 and is headquartered in Marlborough, Massachusetts.
Ansatte
369
Nettsted
Investorrelasjoner
-
SEC-innsendelser
Adm. direktør
Land
USA
By
Aksjetype
-
CCC-status
-
Utbyttefrekvens
-
ARRANGEMENTER OG PRESENTASJONER
ArrangementerPresentasjoner
Loading...
Get the latest news and real-time alerts from Akoya Biosciences, Inc. (AKYA) stock at Seeking Alpha.
20. mars 2023
iO Charts is a Seeking Alpha partner
Akoya Biosciences, Inc. (NASDAQ:NASDAQ:AKYA) Q4 2022 Earnings Conference Call March 6, 2023 5:00 PM ETCompany ParticipantsPriyam Shah - Head, Investor...
7. mars 2023
iO Charts is a Seeking Alpha partner
FORSTÅ VIRKSOMHETEN
Loading...
NYHETER OM SELSKAPET
Seeking AlphaPressemeldinger
Get the latest news and real-time alerts from Akoya Biosciences, Inc. (AKYA) stock at Seeking Alpha.
6. mars 2023
Akoya is finding great interest in its marketplace, as shown by the growth of revenues and product placements. Click here to see our take on AKYA stock.
26. januar 2023
Get the latest news and real-time alerts from Akoya Biosciences, Inc. (AKYA) stock at Seeking Alpha.
9. januar 2023
Akoya Biosciences, Inc. (NASDAQ:NASDAQ:AKYA) Q3 2022 Earnings Conference Call November 7, 2022 5:00 PM ETCompany ParticipantsPriyam Shah - Senior Director,...
8. november 2022
Get the latest news and real-time alerts from Akoya Biosciences, Inc. (AKYA) stock at Seeking Alpha.
7. november 2022
The following slide deck was published by Akoya Biosciences, Inc.
16. september 2022
Akoya Biosciences, Inc. (NASDAQ:NASDAQ:AKYA) Q2 2022 Earnings Conference Call August 8, 2022 5:00 PM ETCompany ParticipantsPriyam Shah - Head of IRBrian...
9. august 2022
Get the latest news and real-time alerts from Akoya Biosciences, Inc. (AKYA) stock at Seeking Alpha.
8. august 2022
Get the latest news and real-time alerts from Akoya Biosciences, Inc. (AKYA) stock at Seeking Alpha.
28. juni 2022
Akoya Biosciences (AKYA) went public in April 2021, raising around $132 million in gross proceeds. See why I rate AKYA stock as a Hold for the near term.
30. mai 2022
iO Charts is a Seeking Alpha partnerNeste side